Ghrelin triggers the synaptic incorporation of AMPA receptors in the hippocampus by Ribeiro, Luis F. et al.
Ghrelin triggers the synaptic incorporation of AMPA
receptors in the hippocampus
Luís F. Ribeiroa,b, Tatiana Catarinoa, Sandra D. Santosa, Marion Benoistc, J. Fiona van Leeuwena,b, José A. Estebanc,
and Ana Luísa Carvalhoa,b,1
aCenter for Neuroscience and Cell Biology and bDepartment of Life Sciences, University of Coimbra, 3004-517 Coimbra, Portugal; and cCentro de Biología
Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid, 28049 Madrid, Spain
Edited by Richard L. Huganir, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved November 21, 2013 (received for review July
23, 2013)
Ghrelin is a peptide mainly produced by the stomach and released
into circulation, affecting energy balance and growth hormone
release. These effects are guided largely by the expression of the
ghrelin receptor growth hormone secretagogue type 1a (GHS-R1a)
in the hypothalamus and pituitary. However, GHS-R1a is ex-
pressed in other brain regions, including the hippocampus, where
its activation enhances memory retention. Herein we explore the
molecular mechanism underlying the action of ghrelin on hippo-
campal-dependent memory. Our data show that GHS-R1a is
localized in the vicinity of hippocampal excitatory synapses, and
that its activation increases delivery of α-amino-3-hydroxy-5-
methyl-4-isoxazole propionic-type receptors (AMPARs) to synap-
ses, producing functional modifications at excitatory synapses.
Moreover, GHS-R1a activation enhances two different paradigms
of long-term potentiation in the hippocampus, activates the phos-
phatidylinositol 3-kinase, and increases GluA1 AMPAR subunit and
stargazin phosphorylation. We propose that GHS-R1a activation in
the hippocampus enhances excitatory synaptic transmission and
synaptic plasticity by regulating AMPAR trafficking. Our study pro-
vides insights into mechanisms that may mediate the cognition-
enhancing effect of ghrelin, and suggests a possible link between
the regulation of energy metabolism and learning.
The appetite-stimulating peptide ghrelin is a 28-aa peptidepredominantly produced by X/A-like cells in the oxyntic
glands of the stomach as well as in the intestine (1), and secreted
into the blood stream. This peptide promotes pituitary growth
hormone secretion, through activation of the growth hormone
secretagogue type 1a receptor (GHS-R1a) or ghrelin receptor
(2). Additionally, ghrelin is involved in the regulation of energy
balance by increasing food intake and reducing fat utilization (3).
Plasma ghrelin levels rise before meals and decrease thereafter
(4), a pattern which is consistent with the implication of ghrelin
in preprandial hunger and meal initiation. Ghrelin is secreted
into the circulation and crosses the blood–brain barrier (5, 6),
but there is also evidence for ghrelin synthesis locally in the brain
(2, 7, 8). The GHS-R1a receptor mRNA was initially found in
the hypothalamus and in the pituitary gland (9), and later detected
in the hippocampus (10). GHS-R1a is a G protein-coupled seven-
transmembrane domain receptor (3), which can signal through
guanine nucleotide-binding protein (G protein) subunit alpha 11
(Gq class) to activate phosphatidylinositol-specific phospholipase
C, generating 1,4,5-triphosphate (IP3) responsible for Ca
2+ in-
tracellular release from endoplasmic reticulum, and diacylglicerol,
which in turn activates protein kinase C (PKC) (11). Ghrelin re-
ceptor activation is also coupled to the phosphatidylinositol 3
(PI3)-kinase signaling cascade in different cellular systems
through a pertussis toxin-sensitive G protein (Gi/oα) (11), and
to protein kinase A (PKA) in isolated hypothalamic neurons,
modulating N-type Ca2+ channels (12).
The finding that GHS-R1a is expressed in the hippocampus
raises the possibility that ghrelin, similarly to other appetite-reg-
ulating hormones such as leptin (13), may affect brain functions
other than those related to endocrine and metabolic regulation
(14). Indeed, in the last few years several studies have shown that
ghrelin increases memory retention in rodents, and that the
hippocampus participates in this effect (6, 15–17). Ghrelin-
deficient mice exhibit decreased novel object recognition, a type
of memory test dependent on hippocampal function (6), sug-
gesting that endogenous ghrelin has a physiological role in im-
proving learning and memory. Additionally, high-fat and high-
glucose diets, which inhibit ghrelin secretion (18, 19), impair
hippocampus-dependent synaptic plasticity and spatial memory
(20, 21). On the other hand, caloric restriction, which results in
an increase in the circulating levels of ghrelin (22), decreases
aging-related deficiencies in cognitive processes (23) while in-
creasing learning consolidation and facilitating synaptic plasticity
(24). Recent evidence suggests an enhancing effect of ghrelin on
long-term potentiation (LTP) in the hippocampus (6, 17), a form
of activity-dependent synaptic plasticity which is the cellular
correlate for learning and memory (25). However, conclusive
evidence is still lacking because one study did not observe effects
of ghrelin on LTP induced by theta burst stimulation (6),
whereas the other only detected effects of ghrelin on a late phase
of LTP [2 h after high-frequency stimulation (17)].
Although the function of ghrelin as a cognitive enhancer is well
documented, the molecular mechanisms that underlie this func-
tion are still poorly understood. Here we have tested whether the
activation of GHS-R1a affects the trafficking of α-amino-3-
hydroxyl-5-methyl-4-isoxazole-propionate receptors (AMPARs),
crucial for the expression of changes in synaptic strength in the
hippocampus (26). We report that GHS-R1a localizes to excit-
atory synapses and that its activation induces the synaptic de-
livery of GluA1-containing AMPAR (GluA1-AMPAR) in rat
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hippocampal cultures and in CA1 cells in organotypic hippo-
campal slices. These changes enhance excitatory synaptic trans-
mission. Furthermore, we show that ghrelin receptor activation
enhances LTP expression in the CA3–CA1 synapse in organo-
typic hippocampal slices, and increases the synaptic and cell-
surface trafficking of GluA1-AMPAR induced by chemical LTP
in hippocampal cultures. Finally, we demonstrate that ghrelin
receptor activation in the hippocampus increases the phosphor-
ylation of GluA1 and stargazin. Taken together our data indicate
that ghrelin receptor activation regulates AMPARs trafficking
underlying synaptic plasticity and learning.
Results
GHS-R1a Localizes to Excitatory Hippocampal Synapses. Previous
evidence suggests that GHS-R1a is expressed in the hippocam-
pus (6, 27–29), but the subcellular localization of GHS-R1a in
hippocampal cells has not been studied. Primary hippocampal
neurons were immunolabeled at 15 d in vitro (DIV) for endog-
enous GHS-R1a. GHS-R1a is distributed throughout dendrites
and forms clusters that partially colocalize with the glutamatergic
synapse markers PSD-95, a postsynaptic scaffold, and Vglut1,
a presynaptic vesicular glutamate transporter (Fig. 1A). To
evaluate the presence of GHS-R1a at excitatory synapses, we
identified regions of overlap between the PSD-95 and Vglut1
signals and measured the GHS-R1a immunolabeling at these
sites (Fig. 1B). We found that 31 ± 0.02% of the clusters
positive for both PSD-95 and Vglut1, presumably correspon-
ding to functional synapses, contain GHS-R1a (Fig. 1 B and C),
which accounts for 36 ± 7.3% of the total GHS-R1a fluores-
cence intensity in dendrites. Interestingly, only 23 ± 0.01% of
the PSD-95 positive sites contain GHS-R1a (Fig. 1C), sug-
gesting that GHS-R1a is preferentially localized to the vicinity
of functional synapses. This distribution pattern was confirmed
in primary hippocampal neurons transfected with GFP-tagged
GHS-R1a (30) and immunolabeled at 16 DIV for GFP (Fig. S1
A–C). Furthermore, we observed that GHS-R1a is enriched in
crude synaptosomes (P2 fraction) purified from adult rat hip-
pocampi (Fig. 1D), consistent with a synaptic expression of
GHS-R1a in the adult rat hippocampus. Finally, we found that
GHS-R1a expression levels significantly increase in cultured
hippocampal neurons from 7 up to 19 DIV (Fig. 1E). Taken
together, this evidence indicates that a significant fraction of
GHS-R1a is localized in the vicinity of hippocampal gluta-
matergic synapses, and that its expression is regulated during
development, thus suggesting a role for ghrelin in regulating
excitatory synaptic transmission.
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Fig. 1. GHS-R1a localizes to excitatory synapses and is developmentally regulated in the hippocampus. (A) Representative immunofluorescence images of 15-
DIV hippocampal neurons in culture stained for GHS-R1a, PSD-95, and Vglut1. (Scale bar: 5 μm.) (B) Quantification of the number of clusters per dendritic
length that are positive for both PSD-95 and Vglut1 and of the number of glutamatergic synapses that contain GHS-R1a (PSD-95/Vglut1/GHS-R1a). n rep-
resents the total number of analyzed cells in four independent experiments. Error bars represent SEM. (C) The fraction of synapses containing GHS-R1a was
calculated by evaluating the presence of GHS-R1a at regions of overlap between PSD-95 and Vglut1 clusters, or at PSD-95 clusters. n represents the total
number of analyzed cells in four independent experiments. Error bars represent SEM. The statistical significance was calculated using the Mann–Whitney test
(**P < 0.01). (D) GHS-R1a is enriched in purified crude synaptosomes. Synaptosomal fractions (P2) isolated from adult rat hippocampi were analyzed for the
presence of GHS-R1a, PSD-95, synaptophysin (Synapt.), and actin, as indicated. The plot indicates the enrichment in each protein in the synaptosomal fraction
relative to hippocampal homogenate fraction (S1), normalized to actin. Error bars represent SEM. The statistical significance was calculated using the Student
t test (*P < 0.05 and **P < 0.01). n represents the number of independent experiments. (E) Developmental profile for the expression of GHS-R1a in hip-
pocampal-cultured neurons. GHS-R1a expression levels increase from 7 to 19 DIV, remaining high up to 21 DIV. The plot represents the mean intensity of GHS-
R1a bands normalized to tubulin, relative to 7 DIV. Error bars represent SEM. The statistical significance was calculated using the Student t test (*P < 0.05). n
represents the number of independent experiments.
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GHS-R1a Activation Enhances Excitatory Synaptic Transmission by
Inducing GluA1-AMPAR Synaptic Delivery. To explore the effect of
ghrelin receptor activation on the cell surface and synaptic ex-
pression of GluA1-AMPAR, we performed quantitative immu-
nofluorescence analysis of the expression of synaptic cell-surface
GluA1 in 19 DIV hippocampal neurons treated with the non-
peptidyl GHS-R1a agonist MK-0677, the synthetic molecule
initially used for expression cloning of the ghrelin receptor (9).
Hippocampal neurons were treated with the GHS-R1a agonist
(1 μM) for 1 h to mimic acute changes in ghrelin levels
throughout the day (4), or with the agonist simultaneously with
the GHS-R1a antagonist [D-Lys3]-GHRP-6 (100 μM), and live
stained with an antibody against an extracellular epitope in the
GluA1 N terminus. After fixation, neurons were stained for
MAP2 to visualize the dendritic structure, and for PSD-95 and
Vglut1 to visualize excitatory synapses (Fig. 2A). We verified that
neuronal treatment with the GHS-R1a agonist for 1 h did not
change the number of Vglut1 clusters per dendritic length (Fig.
2D), and have therefore used Vglut1 as a glutamatergic synaptic
marker in these experimental conditions. Neurons treated with
MK-0677 showed a significant increase in the fluorescence in-
tensity of total (Fig. 2B) and Vglut1-colocalized GluA1 surface
clusters (Fig. 2C), normalized to the number of Vglut1 clusters
per dendritic length; this effect was abolished in the presence of
the GHS-R1a antagonist (Fig. 2 A–C). The role of GHS-R1a
activation on cell-surface expression of GluA1-AMPAR was
further tested in acute hippocampal slices prepared from juve-
nile mice (8–10 wk). We found that treatment with the GHS-R1a
agonist for 2 h significantly increased the cell-surface levels of
GluA1, assessed using a cell-surface biotinylation assay (Fig. 2E).
These observations suggest that MK-0677 increases the levels
of AMPARs at the neuronal surface and at synapses through a
A E
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Fig. 2. Ghrelin receptor activation promotes the synaptic expression of GluA1. (A) Hippocampal neurons 19 DIV were incubated with the ghrelin receptor
agonist MK-0677 (1 μM) for 1 h, with the agonist in the presence of the ghrelin receptor antagonist [D-Lys3]-GHRP-6 (Atg; 100 μM), or with the antagonist
alone. Neurons were live stained for GluA1 using an antibody against an extracellular epitope in the GluA1 N terminus. After fixation, neurons were stained
for PSD-95, Vglut1, and MAP2. (Scale bars: 2 μm.) Neurons were analyzed for the total GluA1 cell-surface fluorescence intensity (B) and for the GluA1 synaptic
cluster (Vglut1-colocalized) fluorescence intensity (C) per number of Vglut1 clusters per dendritic length. (D) The number of Vglut1 clusters per dendritic
length was evaluated. (B–D) Results are expressed as the percentage of control cells, and are averaged from three independent experiments. Error bars
represent SEM. The statistical significance was calculated using the Kruskal–Wallis test (P = 0.0045 and P = 0.0002) followed by Dunn’s multiple comparison test (*P <
0.05 and **P < 0.01). Comparisons between pairs were performed using the Mann–Whitney test (#P < 0.05 and ##P < 0.01). n represents the total number of analyzed
cells in independent preparations. (E) Cell-surface expression of GluA1-AMPAR in acute hippocampal slices as determined using cell-surface biotinylation. (Upper)
Representative Western blots of cell-surface and total GluA1 in control and MK-0677-treated acute slices from 8 to 10-wk mice. (Lower) Corresponding histogram
of GluA1 surface levels. The plot represents the mean intensity of GluA1 bands normalized to the transferrin receptor, relative to untreated slices. Error bars
represent SEM. The statistical significance was calculated using the Student t test (*P < 0.05). n represents the number of independent experiments.
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mechanism that is specifically mediated by the ghrelin receptor.
Moreover, these observations suggest that ghrelin receptor ac-
tivation, in response to an acute increase in ghrelin plasma levels,
modulates the synaptic trafficking of AMPARs.
To directly determine whether GHS-R1a activation induces
the delivery of new AMPARs into synapses, we expressed
GluA1-GFP in CA1 neurons in organotypic hippocampal slice
cultures. Overexpression of GluA1, with a Sindbis virus-expres-
sion system, leads to the formation of homomeric AMPARs
containing the GluA1 subunit (31). These GluA2-lacking re-
ceptors are inwardly rectifying (32–34), and therefore their re-
cruitment to the synapse can be monitored as an increase in the
ratio of the evoked postsynaptic current at –60 mV relative to the
current at +40 mV (rectification index based on ref. 31). In this
system it was previously shown that newly synthesized GluA1-
containing AMPARs are not spontaneously inserted at synapses
unless driven by strong synaptic stimulation or activation of
specific signaling pathways associated with LTP induction (31,
35). Organotypic slice cultures were infected with GluA1-GFP at
1 or 2 DIV, and the electrophysiology recordings were per-
formed at 3 or 4 DIV. Organotypic hippocampal slices were
treated with 1 μM ghrelin, a concentration of ghrelin that was
previously found to result in a maximal effect on the neuronal
firing rate of nigral dopaminergic neurons, and in vivo dopamine
release in the striatum (29). Organotypic slice cultures were
treated for 20 h with the purpose of mimicking fasting, a nutri-
tional status which has been associated with a prolonged increase
in ghrelin circulating levels (4). Treatment of organotypic slices
with ghrelin (1 μM, Fig. 3A) or with the GHS-R1a agonist MK-
0677 (1 μM, Fig. 3B) for 20 h did not change the rectification
index in uninfected cells, indicating that GHS-R1a activation
does not alter the intrinsic rectification properties of endogenous
AMPARs. Interestingly, we found that slice treatment with ei-
ther ghrelin (Fig. 3A) or MK-0677 (Fig. 3B) increases the rec-
tification index in neurons that express GluA1-GFP, strongly
suggesting that ghrelin receptor activation induces synaptic de-
livery of AMPARs. Importantly, the effect of MK-0677 on the
synaptic delivery of GluA1-AMPAR was blocked by the GHS-R1a
antagonist [D-Lys3]-GHRP-6 (100 μM, Fig. 3B). In addition, we
tested whether the observed effect requires synaptic activity, and
found that in the presence of the N-methyl-D-aspartate-type
receptors (NMDARs) antagonist 2-amino-5-phosphonopentanoic
acid (AP5, 100 μM), or of the voltage-gated sodium channel blocker
tetrodotoxin (TTX, 1 μM), the rectification index of GluA1-GFP–
expressing neurons was not significantly changed upon incubation
with the GHS-R1a agonist MK-0677 (Fig. 3B). Taken together
these results indicate that activation of the hippocampal ghrelin
receptor induces delivery of GluA1 homomeric receptors into
synapses in an activity-dependent manner.
To evaluate whether the induction of AMPAR synaptic delivery
mediated by GHS-R1a activation produces a functional modifi-
cation at excitatory CA3–CA1 synapses, 2 or 3 DIV organo-
typic hippocampal slices were treated with the GHS-R1a agonist
MK-0677 (1 μM, 20 h) and electrophysiological recordings were
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Fig. 3. Ghrelin receptor activation induces activity-dependent GluA1-AMPAR synaptic delivery in CA1 neurons. (A and B) Voltage-clamp whole-cell recordings
obtained in CA1 neurons expressing GluA1-GFP (infected cells) and adjacent nonfluorescent neurons (uninfected cells). GluA1 synaptic delivery was quantified as
an increase in the rectification index (RI = I–60/I+40). (A) Ghrelin induces GluA1-AMPAR synaptic delivery in CA1 neurons. Average rectification indices for ghrelin-
treated cells (1 μM, 20 h) and untreated cells. (B) The ghrelin receptor agonist MK-0677 induces activity-dependent GluA1-AMPAR synaptic delivery. Average
rectification indices for untreated cells, ghrelin receptor agonist-treated cells (1 μM, 20 h), ghrelin receptor agonist-treated cells in the presence of the antagonist
of the ghrelin receptor [D-Lys3]-GHRP-6 (Atg; 100 μM), the voltage-gated sodium channel inhibitor TTX, or the NMDAR antagonist AP5. (C and D) Comparison of
evoked synaptic responses in control organotypic hippocampal slices and in slices treated for 20 h with the ghrelin receptor agonist MK-0677 (1 μM). (C) Average
AMPA/NMDA ratios for agonist-treated and control cells. (D) Average NMDA/GABA ratios for agonist-treated and control cells. (A–D) Representative traces
appear above the corresponding bars. Error bars represent SEM. The statistical significance was calculated using the Mann–Whitney test (*P < 0.05, **P < 0.01,
***P < 0.001, #P < 0.05, and ##P < 0.01). n represents the number of cells. (Scale bars: vertical, 50 pA; horizontal, 20 ms.)
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performed at 3 or 4 DIV. The AMPA/NMDA ratio of synaptic
responses significantly increased after MK-0677 treatment
compared with control neurons (Fig. 3C), whereas the NMDA/
GABA ratio was not changed (Fig. 3D). Additionally, MK-0677
treatment did not change the passive membrane properties of
the neuron, indicating that cell-wide ion channel conductance
was not altered (Fig. S2A). The resting membrane potential and
frequency of spontaneous action potential firing were also un-
altered by MK-0677, in both CA1 (Fig. S2B) and CA3 (Fig. S2C)
neurons. We also measured the number of action potentials in
response to current injection [frequency-intensity (f-I) curves in
Fig. S2 D and E], and found no differences for CA1 neurons
between control and agonist-treated slices. CA3 cells did show
more action potential firing after treatment (Fig. S2E). However,
this was not reflected in higher spontaneous activity in either
CA3 or CA1 cells (Fig. S2 B and C). Therefore, it is not likely to
contribute to the AMPAR trafficking and synaptic plasticity
effects that we report in CA1 cells. These results suggest that
GHS-R1a activation produces a functional change at excitatory
CA1 synapses, specifically an increase in AMPARs-mediated
synaptic transmission. In conclusion, this group of results sug-
gests that a sustained GHS-R1a activation enhances excitatory
synaptic transmission by inducing the insertion of new AMPARs
at synapses.
GHS-R1a Activation Enhances Hippocampal LTP. The classic para-
digm for activity-dependent synaptic delivery of AMPARs is
NMDAR-dependent LTP. Because our data suggest that the
synaptic incorporation of AMPARs induced by GHS-R1a acti-
vation is an activity-dependent process, we hypothesized that
GHS-R1a activation may facilitate LTP-like events in the hip-
pocampus. Therefore we tested whether ghrelin receptor acti-
vation affects this form of synaptic plasticity. Hippocampal
organotypic slices (2 or 3 DIV) were treated with the GHS-R1a
agonist MK-0677 (1 μM, 20 h) and LTP was induced in the CA3–
CA1 synapse. LTP induction significantly increased AMPAR-
mediated responses in both MK-0677–treated and untreated
neurons (Fig. 4 A and B). However, MK-0677 application dra-
matically enhanced LTP expression [5.0 ± 0.9-fold potentiation
with MK-0677 vs. 2.3 ± 0.3-fold potentiation in control neurons
(Fig. 4A)]. Additionally, MK-0677 treatment did not have an
effect on the nonpotentiated (unpaired) pathway (Fig. S2F). This
suggests that GHS-R1a activation facilitates classic NMDAR-
dependent LTP. To directly test whether GHS-R1a activation
affects NMDAR-triggered delivery of endogenous GluA1-
containing AMPARs to synaptic sites, we used a neuronal cul-
ture model of LTP [chemical LTP (cLTP)], in which pharma-
cological activation of NMDARs leads to an increase in the
surface expression of AMPARs (36–40). Consistent with pre-
vious results, cLTP induction caused a significant increase in the
fluorescence intensity of total and Vglut1-colocalized GluA1
surface clusters in 19-DIV hippocampal-cultured neurons (Fig. 5
A–C). We found that pretreatment with the GHS-R1a agonist
MK-0677 (1 μM) for 1 h before the cLTP protocol significantly
increases the fluorescence intensity of total (Fig. 5 A and B)
and Vglut1-colocalized GluA1 surface clusters (Fig. 5 A and C)
compared with neurons subjected to cLTP only, suggesting that
GHS-R1a activation increases the cLTP-induced delivery of
endogenous GluA1-AMPAR to synaptic sites. The same effect
was observed for neurons treated for 20 h with MK-0677 (Fig. S3
A–C). The MK-0677-induced increase in the surface expression
of AMPARs upon cLTP was abolished by application of the
GHS-R1a antagonist [D-Lys3]-GHRP-6 (Fig. 5 A–C and Fig. S3
A–C), in agreement with an effect specifically mediated by
ghrelin receptor activation. These data suggest that pretreatment
with the GHS-R1a agonist produces an alteration in the traf-
ficking of AMPARs, which facilitates their recruitment to the
synapse upon cLTP induction. Altogether, these data suggest
that GHS-R1a activation in the hippocampus increases the
AMPARs delivery to synapses, facilitating the expression of LTP-
like events. Therefore, acute as well as chronic ghrelin receptor
activation modulates the mechanisms of AMPAR synaptic traf-
ficking that mediate synaptic plasticity in the hippocampus.
GHS-R1a Activation Induces PKC and PI3-Kinase Pathways and
Increases GluA1 and Stargazin Phosphorylation in the Hippocampus.
Two distinct but interrelated mechanisms regulate AMPAR func-
tion, modulation of the receptor ion channel properties and regu-
lation of the synaptic targeting of the receptor (31, 41), both of
which are regulated by receptor phosphorylation (42). We evalu-
ated key events linked to ghrelin receptor activation and playing an
important role in the trafficking of AMPARs and consequently in
LTP: PKC activation, PI3-kinase activation, GluA1 phos-
phorylation, and stargazin phosphorylation. These biochemical
changes were evaluated in whole-cell extracts from 4-DIV
organotypic hippocampal slices acutely and chronically treated
with the GHS-R1a agonist MK-0677 (1 μM). The activation of
the PI3-kinase pathway was evaluated by the phosphorylation of
the PI3-kinase downstream effector Akt at Ser473. MK-0677 ap-
plication led to rapid (30-min) significant activation of the PI3-
kinase pathway (Fig. 6A). To test whether PI3-kinase activation is
required for GluA1 synaptic expression upon acute GHS-R1a
activation with the agonist, 19-DIV hippocampal-cultured neurons
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Fig. 4. Ghrelin receptor activation enhances NMDAR-dependent LTP in the
hippocampus. (A and B) The ghrelin receptor agonist MK-0677 enhances
long-term synaptic potentiation in the CA3–CA1 synapse. (A, Left) Sample
traces of evoked AMPAR-mediated synaptic responses recorded from CA1
neurons at –60 mV before (light gray line) and after (darker line) LTP in-
duction. (Scale bars: vertical, 50 pA; horizontal, 20 ms.) (A, Right) Organo-
typic slice cultures were incubated in culture medium or in medium
containing the ghrelin receptor agonist MK-0677 (1 μM, 20 h). Plot shows
quantification of average synaptic potentiation from paired pathway 20–30
min after LTP induction. Error bars represent SEM. The statistical significance
was calculated using the Mann–Whitney test (*P < 0.05). n represents the
number of cells. (B) Time course of normalized AMPAR-mediated synaptic
responses before and after LTP induction. For simplicity, each time point in
the plot corresponds to the average of six consecutive stimulations (sampling
rate: 0.2 Hz).
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were treated with the MK-0677 agonist (1 μM, 1 h), or with the
agonist simultaneously with the PI3-kinase inhibitor LY294002 (10
μM), and live stained with an antibody against an extracellular
epitope in the GluA1 N terminus (Fig. 6B). The increase in the
fluorescence intensity of total and Vglut1-colocalized GluA1
surface clusters in neurons incubated with MK-0677 was abolished
in the presence of the PI3-kinase inhibitor (Fig. 6 B–D), thus
suggesting that the rapid increase in GluA1-AMPAR synaptic
surface clusters upon GHS-R1a activation (1 h) is dependent
on the activation of the PI3-kinase pathway.
Phosphorylation of GluA1 at Ser845 and of stargazin at Ser239/240
was evaluated with the corresponding phosphospecific anti-
bodies. GluA1 phosphorylation at Ser845 (a PKA substrate, Fig. 7A)
significantly increased after acute and prolonged treatment
with MK-0677, whereas stargazin phosphorylation at Ser239/240 (a
PKC and CaMKII substrate) was significantly induced after 20 h
incubation with MK-0677 (Fig. 7B), an effect which was abol-
ished by the GHS-R1a antagonist. Interestingly, neither the
NMDAR antagonist AP5 (100 μM) nor the voltage-gated so-
dium channel blocker TTX (1 μM) affected the phosphorylation
of these two substrates triggered by GHS-R1a activation (Fig. 7
A and B), whereas both compounds blocked synaptic insertion of
GluA1-AMPARs (Fig. 3B). This suggests that ghrelin receptor
activation acts through the phosphorylation of these substrates to
prime AMPARs for synaptic incorporation, which is an activity-
and NMDAR-dependent process. Finally, prolonged MK-0677
application led to an up-regulation of the PKC pathway (Fig.
S4A), evaluated by monitoring the phosphorylation of multiple
PKC substrates, and to GluA1 phosphorylation at Ser831 (PKC
and CaMKII substrate, Fig. S4B), and did not change the activity
of CaMKII (Fig. S4C). To test whether activation of PKA (as
suggested by GluA1 phosphorylation at Ser845) or of PKC are
required for GluA1 surface expression following GHS-R1a ac-
tivation, we blocked PKA activity with the PKA inhibitor H-89
(1 μM), or PKC activity with the PKC inhibitor bisindolylma-
leimide IV (BIM-IV, 1 μM), while incubating neurons with MK-
0677, and live stained for cell-surface GluA1 (Fig. 7 C–F). We
found that activation of PKA is required for the acute (1-h) ef-
fect of MK-0677 on cell-surface GluA1 (Fig. 7 C and D), whereas
A
B C
Fig. 5. Ghrelin receptor activation increases the cell-surface trafficking of GluA1-AMPARmediated by cLTP. (A) Nineteen-day in vitro hippocampal neurons in
culture were submitted to the following stimuli: cLTP (300 μM glycine for 3 min in the absence of Mg2+) and cLTP in neurons treated with the ghrelin receptor
agonist MK-0677 (1 μM, 1 h) or simultaneously with the ghrelin receptor agonist and antagonist [D-Lys3]-GHRP-6 (Atg; 100 μM). Neurons were kept at 37 °C
for 20 min (without glycine) and were live stained for surface GluA1. After fixation, neurons were stained for PSD-95, Vglut1, and MAP2. (Scale bars: 2 μm.)
Neurons were analyzed for the total GluA1 cell-surface fluorescence intensity (B) and for the GluA1 synaptic cluster (Vglut1-colocalized) fluorescence intensity
(C) per number of Vglut1 clusters per dendritic length. (B and C) Results are expressed as the percentage of control cells, and are averaged from three to six
independent experiments. Error bars represent SEM. The statistical significance was calculated using the Kruskal–Wallis test (P < 0.0001) followed by Dunn’s
multiple comparison test (*P < 0.05, **P < 0.01, and ***P < 0.001). Comparisons between pairs were performed using the Mann–Whitney test (#P < 0.05 and
##P < 0.01). n represents the number of cells.
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the prolonged (20-h) effect of MK-0677 on cell-surface GluA1
required PKC activity (Fig. 7 E and F).
Collectively, these results strongly suggest that ghrelin re-
ceptor activation initiates signaling mechanisms ultimately pro-
ducing posttranslational modifications in GluA1-AMPAR and in
the AMPAR-associated protein stargazin. These cellular mech-
anisms may be related to an enhancement of excitatory synaptic
transmission, as they may prime GluA1-AMPARs to facilitate
their synaptic delivery.
Discussion
The localization of the ghrelin receptor in the hippocampus
raises the possibility that signaling through this receptor may
control higher brain functions, and represent a molecular link
between energy metabolism and learning capabilities. A decade
ago Carlini et al. first suggested that ghrelin could affect cogni-
tion (15). In this study, intracerebroventricular injection of
ghrelin in rats was found to increase the latency time in the step-
down inhibitory avoidance test, suggesting an increase in mem-
ory retention. Diano et al. showed that ghrelin can enter the
CNS and bind to hippocampal neurons, promoting dendritic
spine formation. Moreover, they observed that ghrelin treatment
of acute hippocampal slices enhances the rise in excitatory
postsynaptic potential slope in the CA1 region after a 10-Hz
stimulation (6). A recent study found that a single ghrelin in-
fusion prolongs the expression of LTP in the dentate gyrus in
vivo (17). Ghrelin knockout animals showed a decreased number
of spine synapses in the hippocampus and impaired performance
in novel object recognition tests, both of which were rapidly re-
versed by ghrelin administration (6). This evidence indicates a
function for endogenous ghrelin in modulating hippocampal
spines and hippocampal-dependent memory, which is further
supported by the fact that ghrelin receptor knockout mice display
impairments in the Morris water maze test (43). Taken together
these studies strongly support a cognition enhancer effect for
ghrelin through its hippocampal action. Ghrelin-mediated sig-
naling could provide the link between metabolic requirements,
feeding and memory retention, facilitating the successful search
for food sources, allowing animals to remember food locations
and to retain the successful approach that was used to find them
(44, 45).
Despite all of the studies implicating ghrelin and ghrelin re-
ceptor-mediated signaling in hippocampal memory processes, little
is known about the cellular and molecular mechanisms underlying
these effects. In the present study we provide evidence that sup-
ports an effect of ghrelin receptor activation on AMPAR synaptic
traffic, broadly accepted as a mechanism for the expression of the
synaptic plasticity processes thought to be the cellular correlates of
learning and memory (46). We found that the ghrelin receptor
partially colocalizes with synaptic proteins of glutamatergic syn-
apses in primary hippocampal neurons, and is enriched in syn-
aptosomes purified from adult rat hippocampus, suggesting that it
is appropriately localized to modulate excitatory transmission.
We report that activation of hippocampal ghrelin receptors
A B
C D
Fig. 6. The ghrelin receptor-induced activation of the PI3-kinase–signaling pathway is required for increased GluA1-AMPAR synaptic trafficking in hippo-
campal cultured neurons. (A, Upper) Western blot analysis of protein extracts from hippocampal slices incubated with culture medium or with medium
containing the ghrelin receptor agonist MK-0677 (1 μM) for 30 min. The primary antibody detected phosphorylation of Akt at Ser473, a residue targeted by
PI3-kinase downstream signaling. Total Akt was also detected and tubulin was used as a loading control. (A, Lower) The graph represents the quantification
of band intensities relative to control extract. Error bars represent SEM. The statistical significance was calculated using the Student t test (*P < 0.05).
n represents the number of independent experiments. (B) Hippocampal neurons 19 DIV were incubated with the ghrelin receptor agonist MK-0677 (1 μM) for
1 h, with the agonist in the presence of the PI3-kinase inhibitor LY294002 (10 μM), or with the inhibitor alone. Neurons were live stained for GluA1 using an
antibody against an extracellular epitope in the GluA1 N terminus. After fixation, neurons were stained for PSD-95, Vglut1, and MAP2. (Scale bars: 2 μm.)
Neurons were analyzed for the total GluA1 cell-surface fluorescence intensity (C) and for the GluA1 synaptic cluster (Vglut1-colocalized) fluorescence intensity
(D) per number of Vglut1 clusters per dendritic length. (C and D) Results are expressed as the percentage of control cells, and are averaged from four in-
dependent experiments. Error bars represent SEM. The statistical significance was calculated using the Kruskal–Wallis test (P = 0.0113 and P = 0.0013) followed
by Dunn’s multiple comparison test (*P < 0.05). Comparisons between pairs were performed using the Mann–Whitney test (#P < 0.05). n represents the total
number of analyzed cells in independent preparations.
Ribeiro et al. PNAS | Published online December 23, 2013 | E155
N
EU
RO
SC
IE
N
CE
PN
A
S
PL
U
S
promotes the synaptic insertion of AMPARs in the hippo-
campus. Ghrelin receptor activation resulted in an activity-
dependent increase in the inward rectification of AMPAR-
mediated responses in CA1 neurons that express GluA1-GFP
in hippocampal slices, and produced an increase in the synaptic
levels of AMPARs in cultured hippocampal neurons. More-
over, we found that ghrelin receptor activation increases the
surface expression of GluA1 in acute hippocampal slices pre-
pared from juvenile mice. These synaptic changes in AMPAR
trafficking were paralleled by an increase in the AMPA/NMDA
ratio of synaptic responses from CA1 neurons upon ghrelin
receptor activation in hippocampal slices. We also show that
activation of the ghrelin receptor dramatically enhances LTP
expression in organotypic hippocampal slices, and increases the
synaptic accumulation of GluA1 triggered by cLTP in cultured
hippocampal neurons. Altogether our data indicate that ghrelin
receptor activation in the hippocampus, besides promoting den-
dritic spine formation as previously shown (6), enhances synaptic
plasticity by delivering AMPARs into synapses.
How does ghrelin receptor activation affect AMPAR traffic?
We found that activation of the ghrelin receptor in the hippo-
campus leads to changes in the phosphorylation of AMPARs and
stargazin. The phosphorylation of Ser845 in GluA1, a substrate
for protein kinase A (47), is increased in slices treated with MK-
0677, in agreement with a previous study showing that ghrelin
can activate PKA in the hippocampus (27), and our data show
that the ghrelin receptor-induced increase on cell-surface GluA1
requires PKA activity. Phosphorylation of Ser845 in GluA1 is
necessary but not sufficient for synaptic incorporation of GluA1-
containing AMPARs (48), and was shown to prime AMPARs for
A B E
C
D
F
Fig. 7. Ghrelin receptor activation triggers changes in GluA1 and stargazin phosphorylation and the PKA and PKC signaling pathways are required for
increased GluA1-AMPAR surface expression induced by ghrelin receptor activation in the hippocampus. (A and B, Upper) Western blot analysis of protein
extracts from hippocampal slices incubated with culture medium or with medium containing the ghrelin receptor agonist MK-0677 (1 μM) for the indicated
periods of time, or with MK-0677 in the presence of the ghrelin receptor antagonist [D-Lys3]-GHRP-6 (Atg; 100 μM), the voltage-gated sodium channel in-
hibitor TTX or the NMDAR antagonist AP5. The primary antibodies detected phosphorylated GluA1 at Ser845 (A), and phosphorylated stargazin at Ser239/240
(B). Total GluA1 was also detected and tubulin was used as a loading control. (A and B, Lower) The graphs represent the quantification of band intensities
relative to control extracts. Error bars represent SEM. The statistical significance was calculated using the one-way analysis of variance (P < 0.0001 and P =
0.0016) followed by Dunnett’s multiple comparison test (*P < 0.05, **P < 0.01, and ***P < 0.001). Comparisons between pairs were performed using the
Student t test (#P < 0.05). n represents the number of independent experiments. (C–E) Hippocampal neurons 19 DIV were incubated with the ghrelin receptor
agonist MK-0677 (1 μM) for 1 h (C and D) or for 20 h (E and F), with the agonist in the presence of the PKA inhibitor H-89 (1 μM) or the PKC inhibitor BIM-IV
(1 μM), or with the inhibitors alone. Neurons were live stained for GluA1 using an antibody against an extracellular epitope in the GluA1 N terminus. After
fixation, neurons were stained for PSD-95, Vglut1 and MAP2. (Scale bars: 2 μm.) Neurons were analyzed for the total GluA1 cell-surface fluorescence intensity
per number of Vglut1 clusters per dendritic length. (D and F) Results are expressed as the percentage of control cells, and are averaged from 2 to 3 in-
dependent experiments. Error bars represent SEM. The statistical significance was calculated using the Kruskal–Wallis test (P < 0.0001 and P = 0.0122) fol-
lowed by Dunn’s multiple comparison test (*P < 0.05 and **P < 0.01). Comparisons between pairs were performed using the Mann–Whitney test (##P < 0.01).
n represents the total number of analyzed cells in independent preparations.
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synaptic delivery by trafficking them to extrasynaptic sites; sub-
sequent synaptic incorporation requires synaptic NMDAR acti-
vation (49). In fact, we observed that ghrelin receptor-triggered
phosphorylation of Ser845 in GluA1 is not affected by TTX or
AP5, but the increase in AMPAR synaptic delivery mediated by
ghrelin receptor activation is blocked by either TTX or AP5,
suggesting an activity and NMDAR-dependent mechanism. These
data suggest that activation of the ghrelin receptor promotes GluA1-
Ser845 phosphorylation, thereby priming GluA1 for synaptic in-
sertion in an activity-dependent manner. Additionally we found
that short-term treatment with the ghrelin receptor agonist acti-
vates the PI3-kinase–signaling pathway, in agreement with a pre-
vious study in the dentate gyrus (17). PI3-kinase has been
implicated in the induction (50) and expression (51) of LTP in
the CA1 hippocampal region, and was found to be required for
AMPAR insertion during LTP (52). PI3-kinase is responsible for
a constant supply of phosphatidylinositol 3,4,5-triphosphate (PIP3)
necessary to ensure PSD-95–mediated clustering of AMPARs at
the postsynaptic membrane (53). Indeed we found that PI3-ki-
nase–signaling activation is necessary for GluA1 synaptic expres-
sion upon 1-h stimulation with the ghrelin receptor agonist in
hippocampal-cultured neurons.
The AMPAR-associated protein stargazin, a substrate for PKC
and CaMKII (54), was also phosphorylated upon prolonged
ghrelin receptor activation in hippocampal slices. Phosphorylation
of Ser831 in GluA1, another PKC/CaMKII substrate, was also
enhanced. We observed an increase in PKC activity upon ghrelin
receptor activation, but could not detect activation of CaMKII,
thus suggesting that stargazin and GluA1-Ser831 are phosphory-
lated by PKC upon ghrelin receptor activation. In fact, the effect
of prolonged exposure to the ghrelin receptor agonist on GluA1
cell-surface expression depends on PKC activity. Phosphorylation
of stargazin promotes synaptic trafficking of AMPARs, and is
required for LTP (54). Upon phosphorylation, stargazin binds to
PDZ domain-containing proteins such as PSD-95 and stops the
diffusion of cell-surface AMPARs at synaptic sites (55), resulting
in increased synaptic AMPAR content.
Together these results suggest that ghrelin receptor activation
induces the synaptic delivery of GluA1-containg AMPARs by
up-regulating the number of AMPARs that are available for
synaptic incorporation, via PKA activity and phosphorylation
of GluA1 at Ser845, as well as through activation of PI3K. With
longer exposures, ghrelin-induced stargazin phosphorylation will
ultimately lead to receptor trapping at the synapse. These
observations suggest that upon sustained ghrelin receptor acti-
vation, the insertion of AMPARs into synapses is further en-
hanced due to their synaptic stabilization by phosphorylated
stargazin. We hypothesize that in a similar way, increased levels
of ghrelin upon fasting might lead to a robust potentiation
of glutamatergic transmission. Interestingly, the biochemical
changes triggered by ghrelin in the hippocampus do not occlude
further LTP expression. In fact, LTP expression in organotypic
hippocampal slices and delivery of GluA1-containing AMPARs
induced by chemical LTP in hippocampal-cultured neurons are
both enhanced upon ghrelin receptor activation. We thus pro-
pose that ghrelin receptor activation-triggered signaling acts on
targets that facilitate rather than induce LTP expression; in fact,
incubation with the ghrelin receptor agonist does not promote
CaMKII activation, a key event in LTP expression. Furthermore,
ghrelin-induced phosphorylation of GluA1-Ser845 or stargazin
are not blocked by TTX or AP5, whereas the ghrelin receptor-
triggered synaptic incorporation of GluA1-AMPARs is activity-
and NMDAR-dependent, suggesting that the cellular mecha-
nisms triggered by ghrelin act to prime AMPAR for synaptic
insertion in an activity-dependent manner, as during LTP.
In conclusion, the present study has provided mechanistic
insights into the synaptic events and molecular cascades that
mediate enhanced cognition produced by ghrelin. Our findings
suggesting that a prolonged period of stimulation of ghrelin re-
ceptor enhances the glutamatergic synaptic transmission and
synaptic plasticity in the hippocampus are in line with a scenario
where synaptic plasticity is enhanced under fasting (24), and are
consistent with the fact that a great number of cognitive tests on
laboratory rodents and nonhumans primates are routinely per-
formed after a period of fasting.
In addition to inducing a robust feeding response through its
hypothalamic action, ghrelin affects other feeding-related behav-
iors including olfactory function (56), motivational aspects of
feeding (57, 58), and hippocampal memory retention (6, 15–17, 43,
59). Similarly to what we describe here for the hippocampal action
of ghrelin, it is possible that the effect of ghrelin on other brain
regions involves the modulation of glutamatergic transmission.
Materials and Methods
Electrophysiology. Voltage-clamp whole-cell recordings were performed
stimulating Schaffer collateral fibers and recording-evoked synaptic
responses from CA1 pyramidal neurons at holding potentials. The AMPA/
NMDA ratios were calculated by acquiring AMPAR responses at –60 mV and
NMDAR responses at +40 mV at a latency at which AMPAR responses were
fully decayed (60 ms after stimulation). Picrotoxin (100 μM) was present in
the external solution to block the GABAAR responses. The NMDA/GABA
ratios were calculated by recording NMDAR responses at –60 mV and
GABAAR responses at 0 mV, in the absence of Mg
2+. CNQX (10 μM) was
present in the external solution to block AMPAR responses. For the rectifi-
cation studies, GluA1-GFP was expressed in CA1 neurons for 48 h, and
AMPAR responses were recorded at –60 mV and +40 mV in the presence of
100 μM AP5 in the external solution and 100 μM spermine in the internal
solution. The rectification index was calculated as the ratio between the
AMPAR synaptic response at –60 mV and +40 mV. LTP was induced using
a pairing protocol by stimulating Schaffer collateral fibers at 3 Hz for 1.5 min
(300 pulses) while depolarizing the CA1 postsynaptic cell to 0 mV.
Quantitative Imaging Analysis. Imaging was performed on a Zeiss Axiovert
200M microscope and on Zeiss LSM 510 Meta or Zeiss LSM710 confocal
microscopes using a 63 × 1.4 numerical aperture oil objective. Images were
quantified using image analysis software (ImageJ). For quantification, sets of
cells were cultured and stained simultaneously, and imaged using identical
settings. The region of interest was randomly selected avoiding primary
dendrites, and dendritic length was measured using MAP2 staining. Mea-
surements were performed in two to six independent preparations, and at
least five cells per condition were analyzed for each preparation. Quanti-
tative imaging quantification was performed as previously described (60).
Statistical Analyses. Statistical differences were calculated according to
nonparametric tests for most part of the cases; when parametric tests were
used, data were first converted to logarithm. Mann–Whitney or Student t
tests were used to compare statistical differences between any two groups.
Comparisons between multiple groups were performed with the Kruskal–
Wallis analysis of variance and one-way analysis of variance followed by
Dunn’s multiple comparison test and Dunnett’s multiple comparison test.
Additional details are available in SI Materials and Methods.
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